Pierre Chatelain

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment

Wayne S. Cutfield, Patrick Wilton, Helge Bennmarker et al. · The Lancet · 2000 · 321 citations

Obesity, Metabolic Syndrome, Diabetes Management +10

Evidence of a specific complex between adriamycin and negatively-charged phospholipids

Erik Goormaghtigh, Pierre Chatelain, J. Caspers et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1980 · 310 citations

Chemical Biology, Proteinlipid Interaction, Lipid Biophysics +8

Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency

Michael B. Ranke, Anders Lindberg, Pierre Chatelain et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 274 citations · Full text

Fertility, Short Stature, Human Growth +16

Binding Characteristics of Cetirizine and Levocetirizine to Human H₁Histamine Receptors: Contribution of Lys¹⁹¹and Thr¹⁹⁴

Michel Gillard, Christy Van Der Perren, Nicole Moguilevsky et al. · Molecular Pharmacology · 2002 · 210 citations · Full text

Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).

M O Savage, Werner Blum, MB Ranke et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 202 citations

Human Growth, Gynecology, Clinical Features +21